VC  Montreux Equity Partners

     Office Locations:

One Ferry Building, Suite 255
San Francisco, CA 94111
Phone: 650-234-1200
Fax: 650-234-1250



  • Early



  • Life Sciences & Healthcare
  • Medical Device



    Founded in 1993, Montreux Equity Partners is a venture capital firm focused on pharmaceutical and medical device companies. Montreux is currently investing out of its fourth fund, MEP IV, a $250 million fund. Montreux's investment ranges from $2-$5 million in any given financing, and up to $12 million over the life cycle of the investment. Montreux typically invests in the first institutional capital raising of clinical and commercialization stage companies.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Silicon Valley Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Daniel K. Turner Managing Director
    Howard D. Palefsky Managing Director
    Jessica Hou Principal
    John J. Savarese MD Managing Director
    Matt Lambert Principal


    Portfolio companies include:

        web link

        web link

        web link

        web link

      Bayhill Therapeutics
        web link

        web link

      Coalescent Surgical
        web link

        web link

      Enteric Medical Technologies
        web link

      GC Aesthetics
        web link

        web link

      Integrated Biosystems
        web link

      KFx Medical
        web link

      MAKO Surgical Corp
        web link

        web link

        web link

        web link

        web link

      Novalar Pharmaceuticals
        web link

        web link

      OREXIGEN Therapeutics
        web link

      Peninsula Pharmaceuticals
        web link

      Percutaneous Systems
        web link

      Pivot Medical
        web link

      Pro-Duct Health
        web link

        web link

      Pure Life Renal
        web link

      Questcor Pharmaceuticals
        web link

      Renal CarePartners
        web link

      Sequel Pharmaceuticals
        web link

        web link

        web link

        web link

      Tobira Therapeutics
        web link

        web link

        web link


    Recent News: